Allstate Corporation’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.1M | Sell |
6,335
-3,494
| -36% | -$1.19M | 0.02% | 499 |
|
|
2025
Q4 | $3.91M | Buy |
9,829
+5,258
| +115% | +$2.33M | 0.05% | 228 |
|
|
2025
Q3 | $2.08M | Buy |
+4,571
| New | +$1.86M | 0.05% | 218 |
|
|
2025
Q2 | – | Sell |
-4,701
| Closed | -$1.27M | – | 194 |
|
|
2025
Q1 | $1.27M | Buy |
4,701
+903
| +24% | +$232K | 0.04% | 285 |
|
|
2024
Q4 | $894K | Buy |
+3,798
| New | +$999K | 0.03% | 341 |
|
|
2023
Q1 | – | Sell |
-5,228
| Closed | -$1.24M | – | 221 |
|
|
2022
Q4 | $1.24M | Buy |
5,228
+78
| +2% | +$16.6K | 0.04% | 302 |
|
|
2022
Q3 | $1.03M | Buy |
5,150
+358
| +7% | +$68.3K | 0.03% | 329 |
|
|
2022
Q2 | $699K | Sell |
4,792
-3,285
| -41% | -$466K | 0.02% | 424 |
|
|
2022
Q1 | $1.32M | Sell |
8,077
-2,782
| -26% | -$424K | 0.04% | 341 |
|
|
2021
Q4 | $1.84M | Buy |
10,859
+5,490
| +102% | +$1.02M | 0.04% | 414 |
|
|
2021
Q3 | $1.01M | Sell |
5,369
-445
| -8% | -$83.5K | 0.04% | 282 |
|
|
2021
Q2 | $986K | Sell |
5,814
-375
| -6% | -$54.9K | 0.03% | 308 |
|
|
2021
Q1 | $874K | Buy |
6,189
+973
| +19% | +$146K | 0.03% | 355 |
|
|
2020
Q4 | $678K | Sell |
5,216
-286
| -5% | -$38.2K | 0.02% | 381 |
|
|
2020
Q3 | $801K | Sell |
5,502
-158
| -3% | -$22.5K | 0.03% | 287 |
|
|
2020
Q2 | $838K | Sell |
5,660
-1,068
| -16% | -$144K | 0.03% | 298 |
|
|
2020
Q1 | $732K | Sell |
6,728
-8,296
| -55% | -$958K | 0.03% | 277 |
|
|
2019
Q4 | $1.73M | Hold |
15,024
| – | – | 0.03% | 332 |
|
|
2019
Q3 | $1.21M | Buy |
15,024
+11,290
| +302% | +$893K | 0.02% | 367 |
|
|
2019
Q2 | $271K | Sell |
3,734
-3,106
| -45% | -$238K | ﹤0.01% | 461 |
|
|
2019
Q1 | $639K | Buy |
6,840
+33
| +0.5% | +$2.76K | 0.02% | 325 |
|
|
2018
Q4 | $496K | Buy |
+6,807
| New | +$524K | 0.02% | 327 |
|
Other funds holding ALNY
VPM
VCM
